Medicines and devices shift back to industry in new European Commission
This article was originally published in Scrip
Executive Summary
The unveiling of the new European Commission on 10 September brought a number of surprises, not least the news that responsibility for the regulation of medicines and medical devices has been moved from the health directorate (Sanco) and will once more come under the industry directorate.